Works matching IS 15233790 AND DT 2013 AND VI 15 AND IP 3
Results: 15
Transplantation for Refractory Germ Cell Tumors: Does it Really Make a Difference?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 232, doi. 10.1007/s11912-013-0309-5
- By:
- Publication type:
- Article
Secondary Cytoreduction Versus Chemotherapy Alone in the Treatment of Patients with Recurrent Ovarian Cancer: Is a Randomized Trial Worthwhile?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 191, doi. 10.1007/s11912-013-0302-z
- By:
- Publication type:
- Article
New Agents in the Arsenal to Fight Castrate-Resistant Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 239, doi. 10.1007/s11912-013-0305-9
- By:
- Publication type:
- Article
Provider Impact on Survival Outcomes in the Management of Malignant Disease.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 193, doi. 10.1007/s11912-013-0304-x
- By:
- Publication type:
- Article
Does Pharmacogenomics Account for Variability in Control of Acute Chemotherapy-Induced Nausea and Vomiting with 5-Hydroxytryptamine Type 3 Receptor Antagonists?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 276, doi. 10.1007/s11912-013-0312-x
- By:
- Publication type:
- Article
Novel Immunotherapies in GU Malignancies.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 224, doi. 10.1007/s11912-013-0306-8
- By:
- Publication type:
- Article
Benefit and Harms of New Anti-Cancer Drugs.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 270, doi. 10.1007/s11912-013-0303-y
- By:
- Publication type:
- Article
Clinical Trials of Neoadjuvant Chemotherapy for Ovarian Cancer: What Do We Gain After an EORTC Trial and After Two Additional Ongoing Trials Are Completed?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 197, doi. 10.1007/s11912-013-0313-9
- By:
- Publication type:
- Article
Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 217, doi. 10.1007/s11912-013-0311-y
- By:
- Publication type:
- Article
Dermatological Adverse Events from BRAF Inhibitors: A Growing Problem.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 249, doi. 10.1007/s11912-013-0308-6
- By:
- Publication type:
- Article
The Role of Vascular Endothelial Growth Factor in the Pathogenesis, Diagnosis and Treatment of Malignant Pleural Effusion.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 207, doi. 10.1007/s11912-013-0315-7
- By:
- Publication type:
- Article
In Reply: Response to Sammartino et al.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 192, doi. 10.1007/s11912-013-0301-0
- By:
- Publication type:
- Article
Personalized Therapy in Gynecological Cancer: A Reality in Clinical Practice?
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 201, doi. 10.1007/s11912-013-0314-8
- By:
- Publication type:
- Article
Follow-Up of Epithelial Ovarian Cancer: Overdue For A Major Rethink.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 204, doi. 10.1007/s11912-013-0310-z
- By:
- Publication type:
- Article
Clearing the Air: A Review of Our Current Understanding of 'Chemo Fog'.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 260, doi. 10.1007/s11912-013-0307-7
- By:
- Publication type:
- Article